CP 0127

Known as: CP-0127 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2009
01219922009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Early pharmacological treatment has the potential to reduce some of the disabling cognitive and behavioral problems that result… (More)
Is this relevant?
Review
2002
Review
2002
The kallikrein-kinin system plays an important role in many physiological and pathophysiological conditions such as homeostasis… (More)
Is this relevant?
1998
1998
 Focal cerebral contusions can be dynamic and expansive, leading to delayed neurological deterioration. Due to the high mortality… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 4
Is this relevant?
1997
1997
OBJECTIVE To test the effect of a novel bradykinin antagonist, deltibant (CP-0127), on survival, organ dysfunction, and other… (More)
Is this relevant?
1997
1997
Isolated rabbit hearts in a modified Langendorff preparation were used to study the role of bradykinin B2-receptor antagonism on… (More)
Is this relevant?
1996
1996
In order to investigate the contribution of kinin receptor antagonism in the treatment of LPS-induced shock we conducted a… (More)
Is this relevant?
1995
1995
In search of new possibilities to prevent acute inflammatory vascular reaction, we examined the effect of two selective B2… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1994
1994
We studied the effects of CP-0127, a novel bradykinin receptor antagonist, in a rat model of traumatic shock. Pentobarbital… (More)
Is this relevant?
1992
1992
The bradykinin antagonist dimer CP-0127 was found to be a potent and selective inhibitor of the depressor response to bradykinin… (More)
Is this relevant?
1992
1992
A systematic study on the dimerization of the bradykinin (BK) antagonist D-Arg0-Arg1-Pro2-Hyp3-Gly4-Phe5-Ser6-D-Phe 7-Leu8-Arg9… (More)
Is this relevant?